Efficacy of melatonin in idiopathic rapid eye movement (REM) sleep behaviour disorder: A double-blind, randomised controlled trial
Phase of Trial: Phase II
Latest Information Update: 16 Jul 2019
Price : $35 *
At a glance
- Drugs Melatonin (Primary)
- Indications Sleep deprivation
- Focus Therapeutic Use
- Acronyms M-iRBD
- 02 Nov 2018 Status changed from recruiting to discontinued.
- 01 Aug 2013 Status changed from not yet recruiting to recruiting as reported by Australian New Zealand Clinical Trials Registry record.
- 02 Jul 2013 New trial record